Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Spondylarthritis 1Cardiovascular Diseases 1Arthritis, Rheumatoid 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Tumor Necrosis Factor Inhibitors × Clear all
NCT04953871 2021-07-08

Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Phase 4 Completed
31 enrolled

Spondylarthritis

NCT01548768 2020-11-27

RHYTHM

Columbia University

Phase 4 Completed
149 enrolled 15 charts

Arthritis, Rheumatoid, Cardiovascular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡